We are live on ! Find out more
AHG

Akso Health Group

4 hedge funds and large institutions have $590K invested in Akso Health Group in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.26% less ownership

Funds ownership: 1.1%0.84% (-0.26%)

43% less funds holding

Funds holding: 74 (-3)

54% less capital invested

Capital invested by funds: $1.28M → $590K (-$689K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
4
Holders Change
-3
Holders Change %
-42.86%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$465K -$109K -96,164 -17%
Two Sigma Investments
2
Two Sigma Investments
New York
$122K -$16K -14,131 -11%
Morgan Stanley
3
Morgan Stanley
New York
$3K -$10.4K -9,188 -73%
Citadel Advisors
4
Citadel Advisors
Florida
-$62K -36,856 Closed
VF
5
Virtu Financial
New York
-$20K -11,671 Closed
Jane Street
6
Jane Street
New York
-$18K -10,650 Closed

AHG Hedge Fund Activity: Q2 2022 in Review

4 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q2 2022, worth a combined $590K — down 54% from $1.28M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AHG and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 0 added.

The largest seller was Renaissance Technologies, cutting an estimated $109K.

  • 4 institutional investors held Akso Health Group (AHG) as of Q2 2022, down from 7 in Q1 2022.
  • Funds reported $590K of Akso Health Group stock for Q2 2022, down 54% quarter-over-quarter.
  • 0 funds opened new Akso Health Group positions in Q2 2022 and 3 closed out, a net change of -3 holders.
  • The largest Akso Health Group seller in Q2 2022 was Renaissance Technologies, an estimated $109K sold.

Based on aggregated 13F filings for Q2 2022.